The effects of SMYD2 and SMYD2-mediated miRNAs on renal cancer cell proliferation, migration, clonogenicity, and tumorigenicity were determined via cell-function assays and murine xenograft experiments. The gene discussed is SMYD2; the disease is renal carcinoma.